Valuation: STAAR Surgical Company

Market Cap 1.13B 1.01B 935M 848M 1.59B 108B 1.61B 11.26B 4.46B 56.39B 4.25B 4.16B 178B P/E 2026 *
77.8x
P/E 2027 * 41.4x
Enterprise Value 939M 838M 774M 702M 1.31B 89.1B 1.33B 9.32B 3.69B 46.68B 3.52B 3.45B 147B EV / Sales 2026 *
2.81x
EV / Sales 2027 * 2.48x
Free-Float
98.41%
Yield 2026 *
-
Yield 2027 * -
1 day+0.53%
1 week+6.30%
1 month+14.19%
3 months-6.53%
6 months-8.98%
Current year-2.08%
1 week 21.15
Extreme 21.15
22.68
1 month 19.7
Extreme 19.7
22.97
Current year 15.58
Extreme 15.585
35.87
1 year 15.58
Extreme 15.585
35.87
3 years 13.5
Extreme 13.5
52.68
5 years 13.5
Extreme 13.5
126.6
10 years 7.46
Extreme 7.455
163.08
Manager TitleAgeSince
Chief Executive Officer 77 2000-12-27
Chief Executive Officer 50 2026-01-31
Director of Finance/CFO 68 2017-04-27
Director TitleAgeSince
Director/Board Member 50 2026-08-03
Director/Board Member 43 2023-11-30
Director/Board Member 55 2024-03-11
Date Insider Type Main position Quantity % Market Cap. Importance
8/14/26 Exercice

Chief Executive Officer

384,004 0.7713%
8/14/26 Exercice

Chief Financial Officer

56,214 0.1129%
8/14/26 Exercice

Executive/Senior Manager

16,554 0.0332%
Change 5-day change 1-year change 3-year change Capi.($)
+0.53%+6.30%-16.14%-45.58% 1.08B
+1.16%-1.13%-17.92%+8.27% 177B
-1.22%+0.70%+1.27%+31.80% 118B
+0.02%+4.24%-19.82%+16.53% 118B
+2.29%+17.36%-41.94%+9.49% 91.21B
-2.21%-2.91%+0.74%+75.30% 64.59B
-1.06%+1.75%+13.50%+80.00% 56.13B
-0.75%+3.73%+6.64%-22.28% 54.59B
-1.13%+0.00%-12.25%+31.02% 43.6B
+0.17%+5.85%-4.92%-10.64% 33.95B
Average -0.22%+4.18%-9.08%+17.39% 75.86B
Weighted average by Cap. -0.02%+3.30%-11.52%+22.57%

Financials

2026 *2027 *
Net sales 334M 299M 276M 250M 468M 31.73B 475M 3.32B 1.31B 16.63B 1.25B 1.23B 52.42B 361M 322M 297M 270M 504M 34.23B 513M 3.58B 1.42B 17.93B 1.35B 1.32B 56.54B
Net income 14.85M 13.26M 12.25M 11.1M 20.77M 1.41B 21.12M 147M 58.37M 739M 55.74M 54.55M 2.33B 28.6M 25.54M 23.59M 21.38M 40M 2.71B 40.66M 284M 112M 1.42B 107M 105M 4.48B
Net Debt -195M -174M -161M -146M -273M -18.53B -278M -1.94B -767M -9.71B -732M -717M -30.6B -241M -215M -199M -180M -337M -22.86B -342M -2.39B -946M -11.98B -904M -884M -37.76B
Projected Income Statement - Annual - STAAR Surgical Company
Logo STAAR Surgical Company
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also markets and sells an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company's principal products are ICLs used in refractive surgery, including its EVO family of lenses.
Employees
921
Date Price Change Volume
26-10-23 US$22.61 +0.53% 345,181
26-10-22 US$22.49 +4.07% 416,254
26-10-21 US$21.61 -3.18% 338,490
26-10-20 US$22.32 +2.01% 614,599
26-10-19 US$21.88 +2.87% 680,346
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - STAAR Surgical Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
22.61USD
Average target price
27.67USD
Spread / Average Target
+22.36%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - STAAR Surgical Company
  1. Stock Market
  2. Stocks
  3. STAA Stock